FWBI
Price:
$2.96
Market Cap:
$5.99M
First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties; and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. The company develops FW-COV, which is in Phase II clinical trials for the treatment of severe acute respiratory syndrome coronavirus 2 gastrointestinal infections; FW-UP, which is in Phase II clinical trials for the treatment ulcerative proctitis and ...[Read more]
Industry
Biotechnology
IPO Date
2016-10-11
Stock Exchange
NASDAQ
Ticker
FWBI
According to First Wave BioPharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.21. This represents a change of -5.19% compared to the average of 1.28 of the last 4 quarters.
The mean historical Current Ratio of First Wave BioPharma, Inc. over the last ten years is 0.92. The current 1.21 Current Ratio has changed 13.11% with respect to the historical average. Over the past ten years (40 quarters), FWBI's Current Ratio was at its highest in in the September 2020 quarter at 4.39. The Current Ratio was at its lowest in in the March 2015 quarter at 0.
Average
0.92
Median
0.79
Minimum
0.23
Maximum
1.60
Discovering the peaks and valleys of First Wave BioPharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 1.60
Minimum Annual Increase = -50.37%
Minimum Annual Current Ratio = 0.23
Year | Current Ratio | Change |
---|---|---|
2023 | 1.58 | 15.11% |
2022 | 1.37 | 79.34% |
2021 | 0.77 | 51.36% |
2020 | 0.51 | -36.34% |
2019 | 0.80 | -50.37% |
2018 | 1.60 | 103.45% |
2017 | 0.79 | -37.80% |
2016 | 1.27 | 439.93% |
2015 | 0.23 | -14.08% |
2014 | 0.27 | Infinity% |
The current Current Ratio of First Wave BioPharma, Inc. (FWBI) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.24
5-year avg
1.00
10-year avg
0.92
First Wave BioPharma, Inc.’s Current Ratio is less than Quoin Pharmaceuticals, Ltd. (3.35), greater than Blue Water Vaccines, Inc. (0.54), less than PaxMedica, Inc. Common Stock (2.40), greater than Revelation Biosciences, Inc. (1.10), less than Hillstream BioPharma, Inc. (2.25), less than Dermata Therapeutics, Inc. (2.73), greater than Panbela Therapeutics, Inc. (0.05), greater than ContraFect Corporation (0.53), greater than SeaStar Medical Holding Corporation (0.24), less than Virios Therapeutics, Inc. (7.27), greater than ZyVersa Therapeutics, Inc. (0.06), less than Sonnet BioTherapeutics Holdings, Inc. (1.65), less than Cardio Diagnostics Holdings, Inc. (5.69), less than Sigilon Therapeutics, Inc. (1.78), less than X4 Pharmaceuticals, Inc. (6.07), less than Zura Bio Limited (12.57), greater than Apexigen, Inc. (0.82), less than Phio Pharmaceuticals Corp. (3.47), greater than eFFECTOR Therapeutics, Inc. (1.03), less than Immix Biopharma, Inc. (7.00),
Company | Current Ratio | Market cap |
---|---|---|
3.35 | $3.06M | |
0.54 | $3.41M | |
2.40 | $834.97K | |
1.10 | $1.43M | |
2.25 | $4.17M | |
2.73 | $2.08M | |
0.05 | $1.75M | |
0.53 | $1.72M | |
0.24 | $20.29M | |
7.27 | $4.94M | |
0.06 | $2.70M | |
1.65 | $4.53M | |
5.69 | $6.94M | |
1.78 | $56.22M | |
6.07 | $109.78M | |
12.57 | $230.86M | |
0.82 | $9.57M | |
3.47 | $2.25M | |
1.03 | $188.18K | |
7.00 | $54.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like First Wave BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like First Wave BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is First Wave BioPharma, Inc.'s Current Ratio?
How is the Current Ratio calculated for First Wave BioPharma, Inc. (FWBI)?
What is the highest Current Ratio for First Wave BioPharma, Inc. (FWBI)?
What is the 3-year average Current Ratio for First Wave BioPharma, Inc. (FWBI)?
What is the 5-year average Current Ratio for First Wave BioPharma, Inc. (FWBI)?
How does the current Current Ratio for First Wave BioPharma, Inc. (FWBI) compare to its historical average?